Skip to content

Your Chief AI Officer Daily Brief

What AI and robotics can do this week, for the Chief Medical Officer and physicians.

Documentation, decision support, clinical workflow, evidence and the hours a physician gets back. Every item below carries a line written for this seat. Subscribe and the weekday brief arrives ordered for it.

Announced2 sourcesFor patients and employeesThursday, November 12, 2026

Chief AI Officer CFO CMO (medical)

Humana launches oncology model to ease prior authorization for cancer drugs

Humana has launched a cancer care model aimed at easing prior authorization for oncology providers, according to a Nov. 10 Humana news release reported by Becker's. The model was developed with the American Oncology Network, which spans more than 350 providers, and specialty care management company Evolent.

Do this week. Have revenue cycle and oncology leaders compare their Humana prior authorization volume and turnaround against the terms of this model, and ask Humana whether participation is open to your group. Run this

The claim.: Humana says the model is aimed at easing the prior authorization process for oncology providers.
The evidence.: No published results on approval times or administrative workload exist yet.

For the Chief Medical Officer and physicians. Ask oncologists where authorization delays most affect treatment start, so participation terms can target them.

For the Chief AI Officer. Track the model as a test case for payer-provider prior authorization redesign that AI tools may need to plug into.

For the CFO and revenue cycle. Quantify staff hours spent on Humana oncology authorizations so you can measure any change if you join.

Read the full item

Sources:Becker's Hospital Review Becker's Payer Issues

Reported5 sourcesFor patientsWednesday, November 11, 2026

Chief AI Officer CEO CMO (marketing)CMO (medical)

Oura agrees to buy AI primary care company Counsel Health for $625 million

Oura agreed to acquire Counsel Health for $625 million in cash, according to a Nov. 10 news release reported by Becker's. The deal combines Oura's continuous biometric monitoring with Counsel's medical AI platform and physician network. STAT notes that Oura recently delayed plans to go public. MedCity News asks whether payers and employers will cover the ring as a benefit, and whether consumers will pay for a more expensive subscription.

Do this week. Decide whether your primary care and wellness lines will accept, refer from or compete with wearable-led AI virtual care, and brief the board on that position. Run this

The claim.: Oura says the acquisition will combine continuous biometric monitoring with Counsel's medical AI and physician network to move from health tracking into clinical care.
The evidence.: No independent evidence on outcomes or cost exists yet, and MedCity News reports that payer and employer coverage remains an open question.

For the Chief AI Officer. Set a policy on whether and how patient-supplied wearable data and outside AI care summaries enter your record.

For the CEO and board. Treat a funded consumer device company that now has a physician network as a possible competitor or partner for primary care relationships.

For the Chief Marketing Officer. Work out how you would stay the trusted clinical relationship for patients who also get AI-led care through a device app.

Read the full item

Sources:Becker's Hospital Review STAT Health Tech MedCity News Athletech News HIT Consultant

Reported1 sourceFor patients and employeesWednesday, November 11, 2026

Chief AI Officer CMO (medical)Compliance CEO

AMA adopts policy that AI cannot be licensed as a physician

The American Medical Association House of Delegates approved a policy on Nov. 9 at its Interim Meeting saying AI cannot be granted physician licensure, professional titles or certification to practice medicine, Becker's reports. The policy calls for AI-enabled tools to be integrated into physician-led teams and used at the direction of physicians. Becker's reports that it also pushes for vendor liability.

Do this week. Review clinical AI vendor contracts for how liability is allocated, and confirm that each tool has a named physician owner. Run this

The claim.: The AMA says AI-enabled tools should operate within physician-led teams and at the direction of physicians.
The evidence.: This is a professional association policy position, not a law or regulation.

For the Chief Medical Officer and physicians. Confirm medical staff policy states who directs and signs off on AI-assisted decisions.

For the Chief AI Officer. Map each clinical AI tool to a supervising physician role in the governance register.

For the Compliance, privacy and legal. Flag contracts that put liability entirely on the organization and renegotiate at renewal.

Read the full item

Sources:Becker's Hospital Review

Heard1 sourceFor patientsMonday, November 9, 2026

Chief AI Officer CMO (medical)Patient experience

Peter Attia says labs reveal about a third of what clinicians need

On The Peter Attia Drive episode #415, Peter Attia said he tells patients that labs reveal roughly a third of what his team wants to know, maybe 25%. He said healthspan dimensions such as strength, cognition and emotional health mostly cannot be captured in a blood draw, and stressed longitudinal data over single snapshots.

Ask your team. Ask your team whether your assessment programs track functional and cognitive measures and keep longitudinal baselines, not only single lab panels. Run this

The claim.: Attia says lab testing is often oversold as a complete report card on health.
The evidence.: Said on a podcast; no study is cited for the share of information labs provide.

For the Chief Medical Officer and physicians. Review how clinicians set patient expectations about what lab panels can show.

For the Chief AI Officer. Check that patient data platforms store results longitudinally so AI tools can read trends, not snapshots.

For the Patient experience. Give patients a clear explanation that lab results are one input among several.

Read the full item

Sources:The Peter Attia Drive

Announced2 sourcesFor patients and employeesFriday, November 6, 2026

Chief AI Officer CMO (medical)CIO and CTO

Mayo Clinic Platform launches AI chatbot for clinical decisions

Clinicians can now query an AI chatbot built on Mayo Clinic's medical knowledge base to help with diagnosis and care decisions across more than 35 specialties, Healthcare Dive reports. HIStalk also covered the launch.

Do this week. Ask your CMO to compare this tool with the chatbots physicians already use and decide which to sanction. Run this

The claim.: Mayo Clinic Platform says the tool streamlines clinical decision-making.
The evidence.: No independent evaluation of the tool is cited in either source.

For the Chief Medical Officer and physicians. Have specialty leads test it against known cases before endorsing it to physicians.

For the Chief AI Officer. Put the tool on the vendor evaluation list alongside any sanctioned clinical chatbot.

Read the full item

Sources:Healthcare Dive HIStalk

Announced2 sourcesFor patients and employeesThursday, November 5, 2026

Chief AI Officer CIO and CTO CMO (medical)

Google shares its framework for evaluating health AI at scale

Google published its framework for building safer and more helpful AI for health, describing how it evaluates health AI at scale. The same week, npj Digital Medicine published a cross-paradigm audit of large language model judges for clinical text evaluation.

Do this week. Compare Google's evaluation framework with how your team currently tests AI tools before go-live, and close the gaps you find. Run this

The claim.: Google says the framework is aimed at safer and more helpful health AI.
The evidence.: This is a company announcement; no independent evaluation of the framework exists yet.

For the Chief Medical Officer and physicians. Review whether automated LLM judges are part of any vendor's quality claims and ask how they were validated.

For the Chief AI Officer. Use published vendor evaluation methods as a reference when writing your own acceptance criteria for clinical AI.

For the CIO and CTO. Ask vendors, including Google, which evaluation results they will share for the specific use you are buying.

Disclosure at publication: Involves Google, a platform Ecofy tracks; editor to confirm any relationship.

Read the full item

Sources:Google Health blog npj Digital Medicine

Announced2 sourcesFor patients and employeesWednesday, November 4, 2026

Chief AI Officer CMO (medical)CIO and CTO

Mayo Clinic Platform launches EHR-integrated decision support across 35-plus subspecialties

Mayo Clinic Platform launched an AI-enabled clinical decision support tool that sits inside the EHR, available to Mayo clinicians and to organizations in the platform's provider network, per Becker's. HIT Consultant reports it covers more than 35 subspecialties with subspecialty chat and multimodal calculators and is designed as a copilot, not an autonomous prescriber.

Do this week. Ask whether your organization qualifies through the Mayo Clinic Platform network and set evaluation criteria before any demo. Run this

The claim.: Mayo says the tool augments clinical judgment rather than replacing it.
The evidence.: No outcome data are reported in either source.

For the Chief Medical Officer and physicians. Name the subspecialty questions where physicians lose the most time and test the tool on those.

For the Chief AI Officer. Compare in-EHR decision support offers against tools already in the portfolio to avoid overlapping copilots.

Disclosure at publication: Ecofy orchestrates Microsoft for clients and says so on every item that names it. The item was selected and checked by the same rules as every other.

Read the full item

Sources:Becker's Hospital Review HIT Consultant

Announced2 sourcesFor patients and employeesTuesday, November 3, 2026

Chief AI Officer CMO (medical)Compliance Patient experience

athenahealth launches a server connecting patient records to Anthropic's Claude

athenahealth on Nov. 2 launched athenaPatient MCP, a server built on the open Model Context Protocol. It lets patients connect their official health record directly to Anthropic's Claude (Becker's, HIT Consultant). The stated aim is conversational interpretation grounded in verified clinical history.

Do this week. Decide how your practice will answer patients who arrive having discussed their own records with Claude, and brief front-line clinicians before those visits start. Run this

The claim.: athenahealth says the integration enables conversational interpretation grounded in verified clinical history.
The evidence.: No independent evidence on patient outcomes or accuracy exists yet; both sources describe the launch.

For the Chief Medical Officer and physicians. Prepare physicians for visits where patients bring AI-generated interpretations of their own charts.

For the Chief AI Officer. Add patient-initiated AI access to records to your governance inventory and set a position on MCP connections before patients ask.

For the Compliance, privacy and legal. Review what patient-directed data sharing to a third-party AI means for your notices and patient education.

For the Patient experience. Draft plain answers for the contact center on what the connection does and who supports it.

Disclosure at publication: Ecofy orchestrates Anthropic for clients and says so on every item that names it. The item was selected and checked by the same rules as every other.

Read the full item

Sources:Becker's Hospital Review HIT Consultant

Reported1 sourceFor patients and employeesTuesday, November 3, 2026

Chief AI Officer Compliance CMO (medical)CEO

AMA assigns liability for clinical AI to vendors and health systems as well as physicians

In a new issue brief, the AMA assigns physicians, AI developers and healthcare organizations distinct responsibilities for clinical AI, Healthcare Dive reported. The AMA argues protecting patients requires all stakeholders to be accountable.

Do this week. Map each clinical AI contract against the AMA's split of responsibilities and close gaps in vendor indemnity and oversight duties. Run this

The claim.: The AMA argues all stakeholders, not only physicians, must be accountable for clinical AI.
The evidence.: This is a policy position in an issue brief, not a court ruling or regulation.

For the Chief AI Officer. Document organizational oversight duties for each clinical AI tool in your governance record.

For the Compliance, privacy and legal. Review indemnification and monitoring clauses in AI vendor contracts against the brief.

Read the full item

Sources:Healthcare Dive

Study2 sourcesFor patients and employeesMonday, November 2, 2026

Chief AI Officer CFO CMO (medical)COO

Medicare's AI-enabled prior authorization pilot linked to nearly 20% drop in some services

A research letter published Oct. 26 in JAMA found that in the first six months of Medicare's Wasteful and Inappropriate Service Reduction (WISeR) pilot, use of targeted services fell in participating states relative to the rest of the country. Researchers from the University of Minnesota School of Public Health and Brown University reported a drop of nearly 20% in some services, as covered by Becker's Hospital Review and Becker's Payer Issues.

Do this week. Pull your own volume and authorization data for WISeR-targeted services in participating states and compare it with the JAMA findings before your next payer review. Run this

The evidence.: The JAMA research letter, as reported by Becker's, links the pilot to a nearly 20% relative drop in use of some targeted services over its first six months.

For the Chief Medical Officer and physicians. Ask physician leaders to review whether care in targeted services is being delayed or forgone and document clinical rationale for appeals.

For the Chief AI Officer. Brief the board that AI-enabled prior authorization now has a measured effect on service volume and add WISeR exposure to the AI risk register.

For the CFO and revenue cycle. Model the revenue effect of a relative volume drop on WISeR-targeted services in participating states and adjust forecasts.

Read the full item

Sources:Becker's Hospital Review Becker's Payer Issues

Announced2 sourcesFor employees and patientsFriday, October 30, 2026

Chief AI Officer CMO (medical)CFO

Ten health systems each passed 1 million AI-documented encounters with Microsoft

Satya Nadella said on Microsoft's fiscal 2027 first-quarter earnings call on Oct. 28 that ten providers, including Advocate Health, Mass General Brigham, Mercy and Intermountain Health, have each documented more than 1 million patient encounters with Microsoft's tools since the start of the calendar year, Becker's reported. Medical Economics separately asked whether AI scribes return their cost.

Do this week. Ask your ambient documentation vendor or pilot lead for encounter volume, physician adoption and time-saved data, and compare it with the scale these systems report. Run this

The claim.: Microsoft presents the milestone as evidence of ambient documentation at enterprise scale.
The evidence.: The figure comes from Microsoft's earnings call; it measures volume, not time saved or quality, and Medical Economics notes the return on AI scribes is still debated.

For the Chief Medical Officer and physicians. Ask physician champions whether after-hours charting has actually fallen, and publish the answer internally.

For the Chief AI Officer. Use peer volume as a benchmark when briefing the board on whether your scribe program is scaling or stalling.

Disclosure at publication: Microsoft is among the platforms Ecofy orchestrates for clients.

Read the full item

Sources:Becker's Hospital Review Medical Economics

Announced1 sourceFor patients and employeesFriday, October 30, 2026

Chief AI Officer Compliance CMO (medical)

AMA releases framework assigning liability when clinical AI harms patients

The American Medical Association released a framework on Oct. 29 that aligns liability for clinical AI harm with each party's authority and ability to prevent or mitigate it, Becker's reported. The AMA Center for Digital Health and AI said existing frameworks were not built for tools that physicians, developers and organizations each partly control.

Do this week. Map each clinical AI tool in production to who controls its configuration, monitoring and override, and check that vendor contracts reflect that split. Run this

The claim.: The AMA says responsibility should follow authority and the ability to prevent harm.
The evidence.: This is a policy framework from a professional association, not law or case precedent.

For the Chief AI Officer. Add a responsibility owner for each AI tool to the governance register using the AMA's control-based logic.

For the Compliance, privacy and legal. Review indemnification and monitoring clauses in AI vendor agreements against the framework before renewals.

Read the full item

Sources:Becker's Hospital Review

Reported2 sourcesFor patients and employeesFriday, October 30, 2026

Chief AI Officer CMO (medical)CNO Compliance

Doximity research finds general AI models err on medication doses

Clinical AI company Doximity released research showing popular general-use AI models get medication doses wrong, some dangerously, and that its own dose verification tool performed better, Healthcare Dive reported. Separately, a family has sued OpenAI over ChatGPT advice on an epilepsy drug taper, Medical Economics reported.

Do this week. Issue clear guidance to clinicians on which AI tools are approved for dosing questions and require pharmacist or reference verification for any AI-suggested dose. Run this

The claim.: Doximity says its dose verification tool outperformed general-use models, which it describes as rife with errors.
The evidence.: The research comes from a vendor comparing its own product and has not been described as peer reviewed; the lawsuit is an allegation, not a finding.

For the Chief Medical Officer and physicians. Remind prescribers that general chatbots are not dose references and route questions through verified sources.

For the Chief AI Officer. Confirm the approved-tools list covers dosing use cases and blocks or flags unapproved chatbots on clinical devices.

For the CNO and nursing. Reinforce that nurses should not act on AI-generated dose information without the standard verification step.

For the Compliance, privacy and legal. Document the policy on clinician use of consumer AI so the organization can show reasonable controls.

Disclosure at publication: Ecofy orchestrates OpenAI for clients and says so on every item that names it. The item was selected and checked by the same rules as every other.

Read the full item

Sources:Healthcare Dive Medical Economics

Reported2 sourcesFor patients and employeesThursday, October 29, 2026

Chief AI Officer CMO (medical)Compliance CMO (marketing)

OpenAI sued over epilepsy death after ChatGPT allegedly advised drug taper

The parents of a 31-year-old Seattle woman with epilepsy filed a wrongful death suit against OpenAI and Sam Altman on Oct. 27 in San Francisco County Superior Court, Becker's reported. The complaint alleges she stopped antiseizure medication on a schedule ChatGPT designed. MedPage Today also covered the filing.

Do this week. Add a line to patient education and after-visit materials telling patients to confirm any medication change suggested by a chatbot with their care team. Run this

The claim.: The plaintiffs allege ChatGPT told the patient to stop taking her seizure medication; the allegations have not been tested in court.
The evidence.: Two outlets report the filing; no court finding exists.

For the Chief Medical Officer and physicians. Ask clinicians to add chatbot use to medication reconciliation questions for patients on high-risk drugs.

For the Chief AI Officer. Brief the board that patients already use consumer chatbots for medication decisions and set a policy for how clinicians ask about it.

For the Compliance, privacy and legal. Review whether any patient-facing AI you deploy can give dosing or taper instructions and document the guardrails.

Read the full item

Sources:Becker's Hospital Review MedPage Today

Reported1 sourceFor employees and patientsThursday, October 29, 2026

Chief AI Officer CFO CMO (medical)Compliance

CMS mandatory Ambulatory Specialty Model starts Jan. 1, 2027 as groups seek delay

The CMS Ambulatory Specialty Model, finalized in the CY 2026 physician fee schedule, ties specialists' Medicare Part B pay to how they manage chronic conditions and starts Jan. 1, 2027, Becker's ASC Review reported. A coalition of provider groups is asking CMS to delay or soften it.

Do this week. Confirm which of your specialists fall under the model and assign an owner to the chronic condition measures before launch. Run this

The claim.: Provider groups in the coalition say the model should be delayed or softened.
The evidence.: The start date comes from CMS's finalized rule as reported; no change to it has been announced.

For the Chief Medical Officer and physicians. Brief specialists on the chronic condition management expectations tied to their pay.

For the Chief AI Officer. Check whether existing analytics or AI tools can report the measures the model uses.

For the CFO and revenue cycle. Model the Part B payment exposure for affected specialists under current performance.

For the Compliance, privacy and legal. Plan to the Jan. 1, 2027 date unless CMS formally changes it.

Read the full item

Sources:Becker's ASC Review

Opinion4 sourcesFor patients and employeesWednesday, October 28, 2026

Chief AI Officer CMO (medical)Compliance

JAMA letters debate guardrails for advertising inside AI decision support tools

Letters in JAMA respond to a Singh and Mello Viewpoint warning that advertising in AI clinical decision support can influence care. One proposes a clinical query firewall; another compares free tools to past drug company giveaways. The authors reply that ending the practice altogether is unlikely.

Do this week. Inventory free or ad-supported AI decision support tools clinicians use and set a policy on which are permitted. Run this

The claim.: The letter writers argue commercial interests can shape medical judgment through ad-supported AI tools, and that clinical queries need protection.
The evidence.: These are opinion letters in JAMA; no study of patient impact is cited.

For the Chief Medical Officer and physicians. Ask physicians which free AI search tools they use and whether they show sponsored content.

For the Chief AI Officer. Add ad-supported tools and query data use to AI vendor review criteria.

For the Compliance, privacy and legal. Review whether clinician queries containing patient details flow to advertisers under tool terms.

Read the full item

Sources:JAMA JAMA JAMA JAMA

Heard1 sourceFor patients and employeesTuesday, October 27, 2026

Chief AI Officer CMO (medical)Patient experience

NEJM AI Grand Rounds: clinician-built previsit tool gathered history before 150,000 visits

On NEJM AI Grand Rounds, Abridge's Dr. Michal Nedoszytko said he built Previsit after seeing that more than half of patients cannot name their medications. Patients texted with an LLM before the visit and the physician received a summary; he said it ran in six countries and completed over 150,000 previsits.

Ask your team. Ask your team whether patient-reported history collected before the visit could improve medication reconciliation in one clinic. Run this

The claim.: Nedoszytko said the goal was better visit quality, not only time saved.
The evidence.: Figures were stated on a podcast; no published study was cited.

For the Chief Medical Officer and physicians. Test whether previsit summaries change the quality of the clinical conversation.

For the Chief AI Officer. Create a sanctioned path for clinician builders to prototype in sandboxes under governance.

For the Patient experience. Design the previsit text as the patient's first contact with the visit.

Read the full item

Sources:NEJM AI Grand Rounds

Announced2 sourcesFor patients and employeesMonday, October 26, 2026

Chief AI Officer CEO CMO (medical)

Dana-Farber names first chief AI officer as Cleveland Clinic forms AI office

Dana-Farber Cancer Institute named Eliezer Van Allen, MD, its inaugural chief AI officer to lead AI strategy, governance and portfolio across research, clinical, operational and administrative work, Becker's reported. Cleveland Clinic Cancer Institute set up an Office of Technology and Digital Strategy, led by oncologists Paul Thambi, MD, and Louis Williams, MD, to evaluate AI tools and streamline adoption, per an Oct. 26 release reported by Becker's.

Do this week. Decide this week who in your organization owns AI governance end to end, and give that person a written mandate covering clinical and administrative use. Run this

The claim.: Both organizations say a dedicated leader or office will speed safe adoption of AI tools.
The evidence.: These are organizational announcements; no outcome data exists yet.

For the Chief Medical Officer and physicians. Consider physician co-leadership of AI evaluation, as Cleveland Clinic did with two oncologists.

For the Chief AI Officer. Compare your charter with Dana-Farber's scope of strategy, governance and portfolio and close gaps.

For the CEO and board. Expect the board to ask who owns AI; name the role and its reporting line.

Read the full item

Sources:Becker's Hospital Review Becker's Hospital Review

Study1 sourceFor employees and patientsSunday, October 25, 2026

Chief AI Officer CMO (medical)CFO CIO and CTO

Jefferson Health ambient AI users closed charts up to 39% faster

A study published Oct. 23 in NEJM Catalyst Innovations in Care Delivery covered 5,234 Jefferson Health clinicians with access to Abridge's ambient documentation tool, Becker's reports. The rollout was associated with up to 16.6% less after-hours documentation and up to 39.3% faster chart closure among the most active users.

Do this week. Set after-hours documentation time and chart closure speed, segmented by usage level, as the scorecard for your own ambient AI pilot or renewal. Run this

The claim.: The authors associate the gains with ambient AI use, concentrated among the most active users.
The evidence.: NEJM Catalyst Innovations in Care Delivery, as reported by Becker's, reports associations rather than a controlled trial, and the largest gains are limited to the heaviest users.

For the Chief Medical Officer and physicians. Ask your ambient AI vendor for chart closure and after-hours time by user tier so you can see whether low adopters need coaching or a different tool.

Read the full item

Sources:Becker's Hospital Review